Interaction of tyrosine kinase inhibitors in practice – a retrospective study based on AOK Plus-prescription data

Kristina Kasek, Katarina Lemnitzer, Carmen Endmann, Ligia-Miky Rolle & Ulf Maywald
Introduction: For the statutory health insurance (SHI) AOK PLUS a good co-operation with oncologists is of great importance to improve the quality of care as well as the drug safety. Therefore, a contract between AOK Plus, Kassenärztlicher Vereinigung Sachsen and German associations of physicians[for full text, please go to the a.m. URL]